Angiodynamics Inc (NASDAQ: ANGO)

AngioDynamics Inc., a prominent player in the medical technology industry, operates under the ticker ANGO. The company is renowned for its commitment to restoring healthy blood flow in the vascular system, broadening cancer treatment options, and enhancing patients' quality of life. AngioDynamics' inception took place in 1988, with its headquarters nestled in Latham, New York, and manufacturing primarily based in Queensbury, New York.

AngioDynamics' business activities revolve around two primary segments: Med Tech and Med Device. The Med Tech segment encompasses the Auryon Atherectomy System, Thrombectomy, AngioVac, NanoKnife, and Microwave Ablation systems. These solutions target various conditions such as peripheral artery disease, deep vein thrombosis, and cancer. On the other hand, the Med Device segment boasts a wide-ranging portfolio of products for minimally invasive procedures. These offerings include angiographic catheters, guidewires, drainage catheters, micropuncture kits, and implantable ports for central venous administration of medications and blood sampling. AngioDynamics' products find application in diverse medical specialties, spanning interventional radiology, interventional cardiology, vascular surgery, urology, and oncology.

The company's revenue generation hinges on the sales of these products and services to a broad customer base. However, specific customer names remain undisclosed in the provided document. AngioDynamics' market presence extends across the United States, where it primarily relies on a direct sales force, and internationally through a blend of direct sales and distributor relationships.

AngioDynamics is not without its fair share of competition. Notable competitors include Boston Scientific Corporation, Cook Medical, Medical Components, Inc. (MedComp), TeleFlex Medical, Becton Dickinson, Medtronic, Merit Medical, Terumo Medical Corporation, Johnson and Johnson, Philips Healthcare, Inari Medical, Varian Medical Systems, and Total Vein Systems. Despite this, AngioDynamics maintains a competitive edge through its strong reputation among interventional physicians, close physician collaboration, dedicated market focus, responsiveness, and execution capabilities for product development and commercialization. The company's competitive position is further bolstered by its robust patent portfolio, trade secrets, manufacturing know-how, technological innovations, and licensing opportunities.

AngioDynamics' product and service portfolio includes the Auryon Atherectomy System, Thrombectomy, AngioVac, NanoKnife, Microwave Ablation systems, angiographic catheters, guidewires, drainage catheters, micropuncture kits, and ports.